patent for semaglutide Expiry to Boost GCC Diabetes and Obesity Treatment | Ata Ul Haque posted on the topic Semaglutide Patent Expiry: Cheaper Weight

Until then, experts are generally skeptical that GLP-1 RAs are a good idea for athletes who dont medically need them

This renders them superior to other whitening procedures because they are capable of not only lightening the skin, but also enhancing the skin texture, fighting aging signs, and detoxifying the body

Ozempic and Mounjaro are not FDA-approved to treat obesity or for weight loss

However, weight loss from GLP-1 therapy may reduce overall cardiovascular strain, potentially supporting modest improvements in blood pressure control over time

Notably, a significant proportion (49.6%) of GLP-1 RAs users had already been on these medications prior to the index hospital discharge

Rybelsus (semaglutide) : the same active ingredient found in Ozempic, but formulated as a once-daily oral tablet instead of an injection